Related Experiment Video
Updated: Sep 19, 2025

A Bright NIR-II Fluorescence Probe for Vascular and Tumor Imaging
Published on: March 17, 2023
A versatile NIR probe for multifunctional detection of tumors, fatty liver, and liver injury
Qihang Ding1,2, Jiqiang Liu3,4, Xinyue Zhang1
1State Key Laboratory of Flexible Electronics (LoFE), Institute of Advanced Materials (IAM), Nanjing University of Posts & Telecommunications 9 Wenyuan Road Nanjing 210023 China iamhzhou@njupt.edu.cn iamcyin@njupt.edu.cn.
Abstract:
Abnormal viscosity, reduced pH, and elevated levels of superoxide anion (O2˙-) in living cells are often associated with various biological dysfunctions and oxidative stress. Although some studies have reported probes capable of detecting one or two of these biomarkers, achieving simultaneous, rapid, and convenient detection of all three remains a significant challenge. Herein, we present a rhodamine based probe, DM301, which selectively activates fluorescence in three distinct channels in response to pH, viscosity, and O2˙- respectively. Systematic spectroscopic analyses demonstrated DM301's exceptional response to these biomarkers, while in vitro experiments confirmed its mitochondrial specificity at the cellular level. To validate the diagnostic potential of DM301, we employed various disease models, including 4T1 tumors, fatty liver, and drug-induced liver injury, all associated with these abnormal biomarkers. In vivo, experiments further established the safety of DM301 and demonstrated its specificity to pH, viscosity, and O2˙- across different pathological conditions in living organisms. We anticipate that these findings will offer practical and effective strategies for investigating the physiological roles of biomarkers and analytes in diverse biological systems.
More Related Videos
05:56Evaluation of the Feasibility, Safety, and Accuracy of an Intraoperative High-intensity Focused Ultrasound Device for Treating Liver Metastases
Published on: January 9, 2019
07:54Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019